Attentional Bias in Body Dysmorphic Disorder

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01398904

Acronym

VAB

Enrollment

Registered

2011-07-21

Start date

2011-03-31

Completion date

2012-07-31

Last updated

2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Dysmorphic Disorders

Keywords

BDD

Brief summary

Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

for BDD and healthy control participants: * males and females 18 years of age or older * sufficient fluency of English to understand study staff, procedures, and questionnaires * ability to provide informed consent Inclusion for BDD participants only; * primary diagnosis of Diagnostic and Statistical Manual 4th Edition (DSM-IV-TR) BDD * BDD Yale-Brown Obsessive Compulsive Disorder score (Y-BOCS) of \> 20 * primary facial/head concern

Exclusion criteria

* Major medical or neurological conditions * schizophrenia, schizoaffective disorder, or any other current lifetime DSM-IV psychotic disorder that is not attributable to delusional BDD * current suicidality * current homicidality

Design outcomes

Primary

Measure	Time frame	Description
Attention Pattern	Day 2	Gaze tracking via an Eyelink II eye tracker will determine perception of visual information.

Secondary

Measure	Time frame	Description
Subjective Units of Distress Scale (SUDS)	Day 2	Participants will provide a distress score based on the facial images observed.
Facial Attractiveness	Day 2	Using a 9-point Likert scale, participants will rate the perceived most attractive and unattractive feature of their own and the control face.

Countries

United States

Outcome results